Table 1 Second-line drug susceptibility results for patient 1 and 2
From: Extensively drug resistant tuberculosis in Mali: a case report
Sample collection date | MTBDRplus rpoB | MTBDRplus katG | MTBDRplus inhA | MTBDRsld gyrA | MTBDRsld rrs | MTBDRsld eis | |
|---|---|---|---|---|---|---|---|
Patient 1 | May 2016 | MUT1 (D516V) | MUT1 (S315T) | MUT3B (T8A) | MUT3C (D94G) | MUT1 (A1401G) | WT |
Patient 2 | May 2016 | MUT1 (D516V) | WT | MUT3B (T8A) | MUT3C (D94G) | MUT1 (A1401G) | WT |
Patient 3 | Feb 2017 | MUT1 (D516V) | MUT1 (S315T) | MUT3B (T8A) | MUT3C MUT3B (D94G) | MUT1 (A1401G) | WT |